
Pembrolizumab after progression on platinum and cetuximab in head and neck squamous cell carcinoma (HNSCC): results from KEYNOTE-055
Haddad, R., Seiwert, T., Pfister, D.G., Worden, F., Liu, S.V., Gilbert, J., Saba, N.F., Weiss, J., Wirth, L.J., Sukari, A., Kang, H., Gibson, M.K., Massarelli, E., Powell, S., Meister, A., Shu, X., ChVolume:
27
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw376.09
Date:
October, 2016
Fichier:
PDF, 42 KB
english, 2016